Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailendra Anoopkumar-Dukie

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Journal of Thrombosis and Thrombolysis|May 8, 2021
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapyNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2021
Signalling transduction of O-GlcNAcylation and PI3K/AKT/mTOR-axis in prostate cancerVivek Makwana, Santosh Rudrawar, Shailendra Anoopkumar-Dukie
Journal of Thrombosis and Thrombolysis|February 22, 2020
The SAMe-TT<sub>2</sub>R<sub>2</sub> score as an indicator of warfarin control for patients with deep vein thrombosis in Queensland, AustraliaNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
International Journal of Clinical Practice|January 10, 2018
Dedicated warfarin care programme results in superior warfarin control in Queensland, AustraliaNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
Biomolecules|March 6, 2021
SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?Yuqing Zhang, Shailendra Anoopkumar-Dukie, Andrew Keith Davey
International Journal of Toxicology|August 28, 2020
Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 CellsVivek Makwana, A/Prof Shailendra-Anoopkumar Dukie, Santosh Rudrawar
Basic & Clinical Pharmacology & Toxicology|October 9, 2016
HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein ThrombosisKylie Mueller, Nijole Bernaitis, Tony Badrick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 15, 2020
The Impact of an Evidence-Based Education on Complementary and Alternative Medicine Usage in People with Cancer: Pilot StudyEllen Simpson, Karly Forster, Sara McMillan, et al.
Prostate International|April 8, 2020
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot studyLiam King, David Christie, Devinder Arora, et al.
European Journal of Pharmacology|June 23, 2024
Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive reviewRadhika Sood, Shailendra Anoopkumar-Dukie, Santosh Rudrawar, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Journal of Thrombosis and Thrombolysis|May 8, 2021
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapyNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 21, 2021
Signalling transduction of O-GlcNAcylation and PI3K/AKT/mTOR-axis in prostate cancerVivek Makwana, Santosh Rudrawar, Shailendra Anoopkumar-Dukie
Journal of Thrombosis and Thrombolysis|February 22, 2020
The SAMe-TT<sub>2</sub>R<sub>2</sub> score as an indicator of warfarin control for patients with deep vein thrombosis in Queensland, AustraliaNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
International Journal of Clinical Practice|January 10, 2018
Dedicated warfarin care programme results in superior warfarin control in Queensland, AustraliaNijole Bernaitis, Tony Badrick, Shailendra Anoopkumar-Dukie
Biomolecules|March 6, 2021
SIRT1 and SIRT2 Modulators: Potential Anti-Inflammatory Treatment for Depression?Yuqing Zhang, Shailendra Anoopkumar-Dukie, Andrew Keith Davey
International Journal of Toxicology|August 28, 2020
Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 CellsVivek Makwana, A/Prof Shailendra-Anoopkumar Dukie, Santosh Rudrawar
Basic & Clinical Pharmacology & Toxicology|October 9, 2016
HAS-BLED Predicts Warfarin Control in Australian Patients treated for Deep Vein ThrombosisKylie Mueller, Nijole Bernaitis, Tony Badrick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 15, 2020
The Impact of an Evidence-Based Education on Complementary and Alternative Medicine Usage in People with Cancer: Pilot StudyEllen Simpson, Karly Forster, Sara McMillan, et al.
Prostate International|April 8, 2020
Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot studyLiam King, David Christie, Devinder Arora, et al.
European Journal of Pharmacology|June 23, 2024
Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive reviewRadhika Sood, Shailendra Anoopkumar-Dukie, Santosh Rudrawar, et al.
Pageof 11